{
    "2018-05-19": [
        [
            {
                "time": "",
                "original_text": "埃克替尼独木难支 贝达药业进入“成长阵痛期”",
                "features": {
                    "keywords": [
                        "埃克替尼",
                        "贝达药业",
                        "成长阵痛期"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}